Since SYT alleviated hepatic steatosis and improved lipid metabolism, we assayed protein levels of SREBP1 and ACC in the liver due to the core role of SREBP1 and ACC in lipogenesis regulation. Here, SREBF1 is linked to fatty liver disease.